Key takeaways
Wegovy sulfur burps are belches that smell like rotten eggs and may be caused by slower digestion, or changes in your diet or gut bacteria while on Wegovy.
Around 7%–13% of people experience increased burping on Wegovy, most commonly when starting Wegovy and when increasing their dose.
Preventing or reducing this side effect may involve changing your eating habits, staying well-hydrated, and possibly adjusting your Wegovy dose after speaking with your healthcare provider.
Here's what we'll cover
Here's what we'll cover
Key takeaways
Wegovy sulfur burps are belches that smell like rotten eggs and may be caused by slower digestion, or changes in your diet or gut bacteria while on Wegovy.
Around 7%–13% of people experience increased burping on Wegovy, most commonly when starting Wegovy and when increasing their dose.
Preventing or reducing this side effect may involve changing your eating habits, staying well-hydrated, and possibly adjusting your Wegovy dose after speaking with your healthcare provider.
From nausea to diarrhea, taking Wegovy (semaglutide) comes with a list of potential side effects that can be uncomfortable, frustrating, and, sometimes, a bit gross. Wegovy sulfur burps can often fall into that last category.
If you’ve noticed an uptick in eggy, sulfur-tasting burps since you started the weight loss and management medication, you’re probably wondering what’s causing them — and more importantly, what you can do to stop them. Sulfur burps can be a common, albeit less-talked-about, side effect of Wegovy.
Read on as we explore what causes Wegovy sulfur burps and offer tips for relief.
What are Wegovy sulfur burps?
Wegovy sulfur burps are rotten egg-smelling belches that you may experience while taking Wegovy as well as other GLP-1 medications. They happen when hydrogen sulfide gas builds up in your digestive tract.
Your digestive system naturally makes hydrogen sulfide gas when breaking down food. But eating sulfur-rich foods or taking certain medications (e.g. Wegovy) can increase the production of this gas, leading to more frequent, foul-smelling burps. Oh and FYI, not only do Wegovy sulfur burps smell sulfuric, but they may taste pretty sulfur-y too.
In clinical trials of Wegovy, 7% of people reported an increase in burping while on the medication. (Although some studies say this side effect impacts as many as 11%–13% of people taking Wegovy.) In most cases, sulfur burps aren’t anything to worry about. But if they’re disrupting your daily life — or you just don’t want to deal with them — talk to your healthcare provider. They can offer specific tips that may help relieve this symptom.
Why does Wegovy cause sulfur burps?
It’s not fully understood why Wegovy causes sulfur burps. But it’s likely due to the drug’s effects on the digestive system.
Wegovy works in part by slowing down how quickly food moves through your digestive tract — a process called gastric emptying. This makes you feel full sooner and longer, leading you to eat less and lose weight However, it can also lead to more gas buildup in the gut, including the kind of sulfur-containing gases that make your burps stinkier.
When digestion slows (such as on Wegovy), it can cause symptoms such as bloating, acid reflux or heartburn, and indigestion. These issues can lead to more burping on their own. So, if you’re dealing with these side effects, you may also experience sulfur burps.
This is especially true if you have a high-sulfur diet. When you eat sulfur-rich foods, there’s a higher chance that hydrogen sulfide gas gets released, and you let an egg-y burp (or two) loose.
Semaglutide, the active ingredient in Wegovy and Ozempic, slows digestion, meaning food stays in your stomach longer. This can allow gut bacteria more time to ferment food, producing gases like hydrogen sulfide, which is responsible for sulfur burps.
Your gut microbiome may also shift as your body adjusts to the medication or dietary changes while on Wegovy.
Prioritizing protein and filling up on fiber are two key eating strategies while taking semaglutide. Maybe you’ve made eggs your new go-to breakfast. Or perhaps you’ve been eating more broccoli (mixed with a lot of garlic). Sound familiar? Good for you. Just know that these foods are high in sulfur, and adjusting your diet can increase the chances of sulfur burps.
That said, more research is needed to fully understand the role of the microbiome in Wegovy sulfur burps.
How long do Wegovy sulfur burps last?
Sulfur burps, like most gastrointestinal side effects of Wegovy, tend to be worse at the beginning of treatment and when increasing your dose. Some studies have found these side effects are most common during the first 8–12 weeks of treatment. But they may last for up to 20 weeks if you titrate up to the highest dosage of Wegovy. Your individual experience may vary.
How can you prevent and treat Wegovy sulfur burps? 4 tips
If you’re experiencing sulfur burps on Wegovy, there are several things you can do to stop them — or even prevent them from occurring in the first place. Strategies are simple, from making small changes to your diet to trying over-the-counter medications.
1. Limit high-sulfur foods
Gut bacteria naturally produce gas as they break down food during digestion. But eating foods high in sulfur can boost the chances of bacteria releasing hydrogen sulfide gas, which is responsible for that rotten egg smell.
When diet is to blame, the fix for foul-smelling burps is relatively easy: Try cutting back on sulfur-rich foods for a while to see if your Wegovy sulfur burps improve.
Examples of high-sulfur foods include:
Eggs
Onions
Garlic
Leeks
Chives
Kidney beans
Dairy products, such as yogurt and mature cheeses
Pastries
Cruciferous vegetables, such as broccoli and Brussels sprouts
2. Drink plenty of water
Proper hydration plays an important part in keeping gas at a minimum and maintaining a healthy gut microbiome. Staying well-hydrated helps your body digest food more easily and move it more swiftly through your digestive tract. This can help prevent gas buildup, so there’s less to release through belching or flatulence.
Drinking lots of water can also relieve other Wegovy side effects like bloating, heartburn, and indigestion — all of which can boost belching.
When choosing drinks to stay hydrated, opt for plain water and sugar-free liquids.
Caffeine, artificial sweeteners, and carbonated beverages (such as soda and even sparkling water) can worsen gas and gastrointestinal distress.
3. Eat smaller, more frequent meals
Eating smaller meals more frequently can relieve some of the GI side effects that lead to sulfur burps on Wegovy, such as acid reflux. It can also help reduce Wegovy sulfur burps by limiting the amount of air you swallow while you eat. (That air has to get released eventually, after all.) To avoid gulping in extra air, take advantage of these tips:
Avoid distractions while you eat, so you can focus on chewing your food with your mouth closed
Wait to speak until you’ve finished chewing
Drink directly from a cup or bottle instead of using a straw
4. Try over-the-counter medication
If lifestyle changes aren’t enough, there’s still hope. Over-the-counter (OTC) medications like Gas-X can help relieve burping by breaking down gas in the digestive tract. Probiotic supplements may also prevent Wegovy sulfur burps by supporting overall healthy digestion.
It’s a good idea to check in with your healthcare provider before adding anything new to your regimen. And be sure to follow the dosage instructions on the label to a tee.
Other medications to consider due to Wegovy sulfur burps
If your Wegovy sulfur burps become too much, your healthcare provider may recommend slowing down your titration schedule or lowering your dosage to relieve side effects. They may also consider switching you to a different weight loss medication altogether.
For example, Zepbound (tirzepatide) and Saxenda (liraglutide) are other meds approved by the US Food and Drug Administration (FDA) for weight loss. Zepbound works a little differently — it targets both GLP-1 and GIP receptors — but it’s often grouped with other GLP-1 medications like Saxenda and Wegovy. Overall, these types of drugs can cause an increase in burping, which makes sense given the way they slow down the gut.
Still, it’s possible you may have a better response to some or one of these medications than others. Plus, studies show that burping is much less common on Saxenda than Wegovy. On the other hand, Zepbound and Wegovy cause belching at around the same rate.
With that in mind, you may want to consider other treatments, such as weight loss pills instead. Here are some options to discuss with your healthcare provider:
Qsymia (phentermine/topiramate) is a daily oral medication that works by reducing appetite and binge eating behaviors. Burps are not considered a common side effect.
Contrave (naltrexone/bupropion) is a twice-daily oral medication that lowers your appetite and food cravings. Burping may occur, but it’s rare enough to not be considered a common side effect.
Xenical (orlistat) is a thrice-daily oral medication that works by decreasing the amount of fat you absorb from the food. Belching is not a common side effect of orlistat, but other GI symptoms are possible.
Keep in mind that all medications come with their risks and benefits. So, you will need to have a conversation with your healthcare provider to better understand the pros and cons of each option.
When to see a healthcare provider about Wegovy sulfur burps
Usually, Wegovy sulfur burps are not anything to worry about. They may go away on their own as your body gets used to the medication or with lifestyle modifications. But you may want to see your healthcare provider if your belching is:
Ongoing and not improving with dietary or lifestyle changes
Accompanied by severe nausea, vomiting, or abdominal pain
Affecting your ability to eat, sleep, or socialize
If you experience any of these situations, contact your healthcare provider. They can help rule out other conditions, such as gastroesophageal reflux disease (GERD), suggest a change to your Wegovy dosing schedule, or recommend a different treatment. If you are experiencing severe symptoms, don’t hesitate to seek emergency medical attention.
What other side effects does Wegovy cause?
Sulfur burps are just one of several possible side effects you may experience on Wegovy. Most, but not all, of the drug’s common side effects are gastrointestinal in nature and often improve over time as your body adjusts to the medication.
Common side effects include:
Diarrhea
Vomiting
Stomach pain
Upset stomach or indigestion
Dizziness
Bloating
Burping
Flatulence
Stomach flu-like symptoms
Heartburn or acid reflux
Common cold-like symptoms
Hypoglycemia (low blood sugar) in people with type 2 diabetes
More serious side effects are also possible but are less likely. The prescribing information has more complete information.
If you experience any side effects on Wegovy, contact your healthcare provider. And if your symptoms are severe or concerning, seek emergency medical attention.
Bottom line
If you’ve read any Wegovy reviews, you know that sulfur burps can be a bit of an unpleasant side effect of the medication. Here’s what to remember:
Wegovy sulfur burps are belches with a foul smell reminiscent of rotten eggs experienced while taking GLP-1. They’re likely the result of the medication’s effects on the digestive tract.
By slowing how fast food moves through the gut, Wegovy can lead to more gas buildup in the gut and, in turn, belching. In clinical trials, 7%--13% of people taking Wegovy experienced burping.
Lifestyle changes can help alleviate Wegovy sulfur burps. These include avoiding high-sulfur foods, staying hydrated, eating smaller and more frequent meals, and trying OTC treatments.
Like other GI side effects, Wegovy sulfur burps may go away on their own as your body gets used to the medication. But if your sulfur burps become disruptive or don’t abate with lifestyle changes, talk to your healthcare provider. They may adjust your dosage or suggest an alternative medication.
Frequently asked questions (FAQs)
How do you stop sulfur burps on semaglutide?
To stop sulfur burps on semaglutide, avoid sulfur-rich foods (e.g. eggs, garlic, dairy), drink more water, limit carbonated beverages, and eat smaller meals more slowly. Probiotics and over-the-counter treatments may also help. But it’s always a good idea to talk to your healthcare provider before trying any new treatments. (FYI, there’s no guaranteed way to “stop” the side effect; these tactics are focused on reducing semaglutide sulfur burps — perhaps to the point where they go away.)
How do you get rid of sulfur burps with medication?
Over-the-counter gas relief medications like Gas-X may help you get rid of sulfur burps. They work by breaking down the gas in your digestive tract. Probiotic supplements may also help stop the side effect since they support an overall healthy gut and digestion. Before starting any new medication or supplement, be sure to consult your healthcare provider.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Saxenda Important Safety Information: Read more about serious warnings and safety info.
Dordević, D., Jančíková, S., Vítězová, M., et al. (2020). Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes. Journal of Advanced Research, 27, 55–69. doi: 10.1016/j.jare.2020.03.003. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7728594/
Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. doi: 10.1038/s41591-022-02026-4. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9556320/
Giuntini, E. B., Sardá, F. A. H., & de Menezes, E. W. (2022). The Effects of Soluble Dietary Fibers on Glycemic Response: An Overview and Futures Perspectives. Foods (Basel, Switzerland), 11(23), 3934. doi: 10.3390/foods11233934. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9736284/
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., et al. (2022). Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine, 12(1), 145. doi: 10.3390/jcm12010145. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9821052/
Ghusn, W. & Hurtado, M. D. (2024). Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks. Obesity Pillars, 12, 100127. doi: 10.1016/j.obpill.2024.100127. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11404059/
Latif, W., Lambrinos, K. J., Patel, P., et al. (2024). Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs). StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK572151/
Loomba, R., Abdelmalek, M. F., Armstrong, M. J., et al. (2023). Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. The Lancet. Gastroenterology & Hepatology, 8(6), 511–522. doi: 10.1016/S2468-1253(23)00068-7. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10792518/
MedlinePlus. (2023). Gas. Retrieved from https://medlineplus.gov/gas.html
MedlinePlus. (2018). Simethicone. Retrieved from https://medlineplus.gov/druginfo/meds/a682683.html
Passafiume, A., Rossetti, A., Vescovi, L., et al. (2023). Sulfur content in foods consumed in an Italian population and impact of diet quality on sulfur intake. Journal of Food Composition and Analysis, 123, 105543. doi: 10.1016/j.jfca.2023.105543. Retrieved from https://www.sciencedirect.com/science/article/pii/S0889157523004179
Procházková, N., Falony, G., Dragsted, L. O., et al. (2023). Advancing human gut microbiota research by considering gut transit time. Gut, 72(1), 180–191. doi: 10.1136/gutjnl-2022-328166. Retrieved from https://gut.bmj.com/content/72/1/180
Rubino, D. M., Greenway, F. L., Khalid, U., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. doi: 10.1001/jama.2021.23619. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8753508/
Sato, K., Hara-Chikuma, M., Yasui, M., et al. (2024). Sufficient water intake maintains the gut microbiota and immune homeostasis and promotes pathogen elimination. iScience, 27(6), 109903. doi: 10.1016/j.isci.2024.109903. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11126815/
Shu, Y., He, X., Wu, P., et al. (2022). Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health, 10, 996179. doi: 10.3389/fpubh.2022.996179. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9631444/
Smits, M. M. & Van Raalte, D. H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12, 645563. doi: 10.3389/fendo.2021.645563. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8294388/
Tchang, B. G., Aras, M., Kumar, R. B., et al. (2024). Pharmacologic Treatment of Overweight and Obesity in Adults. Endotext. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK279038/
U.S. Food and Drug Administration (FDA-a). (2024). Highlights of Prescribing Information: Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/200063s022lbl.pdf
U.S. Food and Drug Administration (FDA-a). (2025). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s025lbl.pdf
U.S. Food and Drug Administration (FDA-b). (2024). Highlights of Prescribing Information: Qsymia (phentermine and topiramate extended-release capsules), for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022580s029lbl.pdf
U.S. Food and Drug Administration (FDA-b). (2025). Highlights of Prescribing Information: Saxenda (liraglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206321s020lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2024). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf
U.S. Food and Drug Administration (FDA). (2022). Highlights of Prescribing Information: Xenical (orlistat) Capsules, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020766s038lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2025). Highlights of Prescribing Information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806Orig1s020lbl.pdf
Wharton, S., Calanna, S., Davies, M., et al. (2022). Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, Obesity & Metabolism, 24(1), 94–105. doi: 10.1111/dom.14551. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9293236/
Wilkinson, J. M., Cozine, E. W., & Loftus, C. G. (2019). Gas, Bloating, and Belching: Approach to Evaluation and Management. American Family Physician, 99(5), 301–309. Retrieved from https://www.aafp.org/pubs/afp/issues/2019/0301/p301.html
Zeng, Y., Wu, Y., Zhang, Q., et al. (2024). Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio, 15(1), e0203223. doi: 10.1128/mbio.02032-23. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10790698/
Zhou, Y., Chen, M., Liu, L., et al. (2022). Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 155–163. doi: 10.2147/DMSO.S348025. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8763271/